Skip to content

Medical emergency? What to do

New treatments improve lymphoma survival

3-RXPublished November 3, 20051 min read

Key points

  • New treatments incorporating immunotherapy - strategies that boost the immune system -- have significantly improved overall survival of patients with a blood cancer called follicular lymphoma, according to a new report.
  • "In our studies," the investigators write, "treatment with CHOP combination chemotherapy followed by an monoclonal antibody therapy seems to be the best option."
  • The study also shows that so-called disease progression-free survival curves for the CHOP and ProMACE regimens essentially overlapped, the authors report, with estimated 4-year progression-free survival rates of 46 percent and 48 percent, respectively.
  • SOURCE: Journal of Clinical Oncology, Online October 17, 2005.

New treatments incorporating immunotherapy - strategies that boost the immune system -- have significantly improved overall survival of patients with a blood cancer called follicular lymphoma, according to a new report.

Emerging data suggest that for patients with follicular lymphoma "initial treatment choices may matter," Dr. Richard I. Fisher from University of Rochester in New York told Reuters Health.

Fisher and colleagues compared outcomes of patients with follicular lymphoma treated with three commonly used sequential treatment approaches: CHOP with or without nonspecific immunostimulants; ProMACE plus MOPP with or without interferon; and CHOP followed by monoclonal antibody therapy with rituximab or 131I-tositumomab.

"In our studies," the investigators write, "treatment with CHOP combination chemotherapy followed by an monoclonal antibody therapy seems to be the best option."

Four-year estimates of overall survival showed progressive increases from 69 percent survival at 4 years with CHOP to 79 percent survival with ProMACE to 91 percent with CHOP plus monoclonal antibody therapy, the researchers note.

The study also shows that so-called disease progression-free survival curves for the CHOP and ProMACE regimens essentially overlapped, the authors report, with estimated 4-year progression-free survival rates of 46 percent and 48 percent, respectively.

The 4-year estimated progression-free survival was significantly improved with CHOP plus monoclonal antibody therapy (61 percent), the authors also report in the Journal of Clinical Oncology.

SOURCE: Journal of Clinical Oncology, Online October 17, 2005.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underCancer

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.